1) FRANCESCO ORCIUOLI, PROFESSORE ASSOCIATO DELL'UNIVERSITA' DEGLI STUDI DI SALERNO - DIPARTIMENTO DI SCIENZE AZIENDALI - MANAGEMENT & INNOVATION/DISA-MIS. DOCENTE DI INFORMATICA, MEMBRO IEEE. DAL 1999 HA CONDOTTO NUMEROSI PROGETTI DI RICERCA E SVILUPPO SPERIMENTALE, AUTORE DI OLTRE 100 PUBBLICAZIONI. ESPERTO DI SISTEMI DI SUPPORTO ALLE DECISIONI, BASATI SU PARADIGMA DELLA SITUATION AWARENESS. 2) GIUSEPPE FENZA, RICERCATORE PRESSO IL DIPARTIMENTO DI SCIENZE AZIENDALI - MANAGEMENT & INNOVATION SYSTEMS/DISA-MIS DELL'UNIVERSITA' DEGLI STUDI DI SALERNO. ASSISTANT PROFESSOR IN INFORMATICA, MEMBRO IEEE. DAL 2005 HA CONDOTTO NUMEROSI PROGETTI DI RICERCA E SVILUPPO SPERIMENTALE. ESPERTO DI ANALISI DI DATA E ARCHITETTURE SOFTWARE SEMANTIC-ENABLED. FONDATORE DI START-UP, NELL'AMBITO DEL PROGRAMMA OXYGEN ACCELERATOR NEL CAMPUS DI GOOGLE A LONDRA. 3) LUCA ROMANELLI: INGEGNERE, CON MASTER IN BUSINESS ADMINISTRATION. ESPERIENZA VENTENNALE NELLA GESTIONE E AMMINISTRAZIONE DI AZIENDE IN AMBITO INFORMATICO (KPMG, MOMA). HA MATURATO ESPERIENZA DI BUSINESS DEVELOPMENT IN AZIENDA LEADER DEL SETTORE MEDICALE, COME AB MEDICA.
Professional relationships with incubators, investors and research universities
LA SOCIETA' SI CONFIGURA COME "SPIN-OFF" APPROVATO DALL'UNIVERSITA' DEGLI STUDI DI SALERNO, CON DELIBERA DEL SENATO ACCADEMICO DELL'11 LUGLIO 2017 E DEL CONSIGLIO DI AMMINISTRAZIONE DEL 13 LUGLIO 2017.
List of privative rights on industrial, intellectual property
Macro-sector ICT (Electrical and Electronic, Computer Science, Research and Development)
Are you the legal representative?
RiAtlas is a healthcare digital start-up, powered by Artificial Intelligence (AI) technology, strongly committed to address Precision Medicine. We research and develop data analytics tools for value-based Clinical Application. The final scope is to support Clinical Decisions, improve Patients’ Quality of Life and Outcomes, and reduce Social and Health Care System costs.
RiAtlas is an approved spin-off by University of Salerno.
A value based healthcare digital application, exploiting the potential of Artificial Intelligence (AI) and Internet of Things (IoT), through Integrated “Care Pathway”, for real-time Clinical Decisions and active Patient Engagement, addressing patients, after a post-acute phase, and facilitating the return in their living environment (de-hospitalization).
The final scope is to support physicians’ clinical decision and to improve user’ engagement and quality of life.
GEOGRAPHIC AREA OF INTEREST
Abroad European Union
Large-scale retail channel
Holding licenses owned intellectual with the entity and/or to the founder and/or third parties
Patent for industrial invention
Short description of the aspects of innovation that characterize the business enterprise
The solution adopts a patient-centred approach, able to offer innovative user profiling, intelligent alerting and self-monitoring services.
There are no loans and / or investments for the company to report
The company has trade relations with business associations, universities and research centers